BiotechTube
Home/Pipeline/Meta10-TILs

Meta10-TILs

Advanced Solid Tumors

Phase 1Active (Investigator-Initiated Trial)

Key Facts

Indication
Advanced Solid Tumors
Phase
Phase 1
Status
Active (Investigator-Initiated Trial)
Company
Leman Biotech

About Leman Biotech

AI-enabled metabolic cancer immunotherapy company developing next-generation metabolically armored cell therapies to cure solid tumors and hematological cancers.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Advanced Solid Tumors Drugs

DrugCompanyPhase
NT219Purple BiotechPhase 1/2
INDP-101Indaptus TherapeuticsPhase 1
NST-101 (estimated)Novastage PharmaceuticalsPhase 1/2
PM14PharmaMarPhase 1/2
Ecubectedin (PM54)PharmaMarPhase 1
M8891Merck KGaAPhase 1/2
P-002Panacea BiotecPhase 1/2
Undisclosed kinase inhibitorTyligand BiosciencePhase 1
TYK-001TYK MedicinesPhase 1/2
PT-112SciClone PharmaceuticalsPhase 1
AP-202Advance PharmaceuticalPhase 1/2
BP1001-ABio-Path HoldingsPhase 1